1-(1H-benzimidazol-2-yl)-3-(3-fluorophenyl)-2-propen-1-one | 1426813-73-1

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 1-(1H-benzimidazol-2-yl)-3-(3-fluorophenyl)-2-propen-1-one
• CAS: 1426813-73-1
• 化学式: C₁₆H₁₁FN₂O
• 分子量: 266.275
• InChiKey: IORJHLWQVAFYCF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  20.0
• 可旋转键数：
  3.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  45.75
• 氢给体数：
  1.0
• 氢受体数：
  2.0

反应信息

• 作为反应物：
  描述：

  1-(1H-benzimidazol-2-yl)-3-(3-fluorophenyl)-2-propen-1-one 、 2-氯甲基-5-苯基-1,3,4-噁二唑 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以78%的产率得到3-(3-fluorophenyl)-1-{1-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]-1H-benzimidazol-2-yl}-2-propen-1-one
  参考文献：
  名称：

  Synthesis, characterization, and antimicrobial activity of benzimidazole-derived chalcones containing 1,3,4-oxadiazole moiety

  摘要：

  A series of novel benzimidazole-derived chalcones containing the 1,3,4-oxadiazole moiety were synthesized and characterized by IR, H-1, C-13 NMR, and mass spectra and elemental analysis. The synthesized compounds were evaluated for their efficiency as antibacterial agents against two Gram-positive and Gram-negative strains of bacteria along with antifungal activity against three fungal species. Antibacterial activity revealed that tested compounds exhibited potent activity whereas some compounds exhibited moderate antifungal activity as compared to the standards.

  DOI：

  10.1007/s10593-015-1653-1
• 作为产物：
  描述：

  2-(1-羟乙基)苯并咪唑 在 potassium dichromate 、 硫酸 、 sodium hydroxide 作用下， 以 乙醇 为溶剂， 反应 15.0h， 生成 1-(1H-benzimidazol-2-yl)-3-(3-fluorophenyl)-2-propen-1-one
  参考文献：
  名称：

  Synthesis, characterization, and antimicrobial activity of benzimidazole-derived chalcones containing 1,3,4-oxadiazole moiety

  摘要：

  A series of novel benzimidazole-derived chalcones containing the 1,3,4-oxadiazole moiety were synthesized and characterized by IR, H-1, C-13 NMR, and mass spectra and elemental analysis. The synthesized compounds were evaluated for their efficiency as antibacterial agents against two Gram-positive and Gram-negative strains of bacteria along with antifungal activity against three fungal species. Antibacterial activity revealed that tested compounds exhibited potent activity whereas some compounds exhibited moderate antifungal activity as compared to the standards.

  DOI：

  10.1007/s10593-015-1653-1

文献信息

• Synthesis and characterization of novel benzimidazole bearing pyrazoline derivatives as potential antimicrobial agents
  作者：N. C. Desai、D. D. Pandya、G. M. Kotadiya、Priyanka Desai

  DOI：10.1007/s00044-013-0756-4

  日期：2014.3

  A new series of compounds N-(4-(2-(3-(1H-benzo[d]imidazol-2-yl)-5-(aryl)-4,5-dihydro-1H-pyrazol-1-yl)-2-oxoethoxy)phenyl)acetamides (5a–u) were synthesized and structures of these compounds were elucidated by spectral (IR, 1H NMR, 13C NMR, and mass spectra) analysis. Antimicrobial activity was measured against Escherichia coli (MTCC 443), Pseudomonas aeruginosa (MTCC 1688), Staphylococcus aureus (MTCC

  一系列新的化合物N-（4-（2-（3-（1 H-苯并[ d ]咪唑-2-基] -5-（芳基）-4,5-二氢-1 H-吡唑-1-合成了yl）-2-氧代乙氧基）苯基）乙酰胺（5a - u），并通过光谱分析（IR，1 H NMR，13 C NMR和质谱）阐明了这些化合物的结构。测量了对大肠杆菌（MTCC 443），铜绿假单胞菌（MTCC 1688），金黄色葡萄球菌（MTCC 96），化脓性链球菌（MTCC 442），白色念珠菌（MTCC 227），黑曲霉（Aspergillus niger）的抗菌活性（MTCC 282）和曲霉曲霉（MTCC 1323）的连续肉汤稀释法。抗菌活性的评估表明，与标准药物相比，化合物5f，5i，5q和5t是最有效的抗菌剂，而化合物5e，5g，5h，5j，5p，5r和5u是最有效的抗菌剂，因此有望成为新的铅分子。
• Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidazole small molecules
  作者：Assem Barakat、Saeed Alshahrani、Abdullah Mohammed Al-Majid、Abdullah Saleh Alamary、Matti Haukka、Marwa M. Abu-Serie、Alexander Dömling、Luis R. Domingo、Yaseen A. M. M. Elshaier

  DOI：10.3389/fphar.2024.1358089

  日期：——

  quantified using IC50 values. This study highlights activation of the p53 pathway by compounds 6a and 6d, leading to upregulation of p53 expression and downregulation of cyclin D and NF-κB in treated cells. Additionally, we explored the binding affinity of spirooxindole analogs, particularly compound 6d, to MDM2, a protein involved in regulation of p53. The binding mode and position of compound 6d were

  本研究讨论了新的螺吲哚-苯并咪唑化合物库的合成和用途，作为信号转导器的抑制剂和 p53 的激活剂，p53 是一种参与调节细胞生长和癌症预防的蛋白质。该文本包括分子电子密度理论框架内偶氮甲碱叶立德 7a 和乙烯 3a 之间的 [3 + 2] 环加成 (32CA) 反应的科学细节。 32CA反应的机理是通过两阶段一步过程，重点是高度异步的过渡状态结构。评估了合成化合物，特别是6a和6d的抗癌特性。使用 IC 定量这些化合物对肿瘤细胞（MDA-MB 231 和 PC-3）生长的抑制作用50价值观。这项研究强调了化合物 6a 和 6d 激活 p53 通路，导致处理细胞中 p53 表达上调以及细胞周期蛋白 D 和 NF-κB 下调。此外，我们还探讨了螺吲哚类似物（特别是化合物 6d）与 MDM2（一种参与 p53 调节的蛋白质）的结合亲和力。将化合物 6d 的结合模式和位置​​与共结晶标准配体的结合
• New spiro-indeno[1,2- <i>b</i> ]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insights
  作者：Assem Barakat、Saeed Alshahrani、Abdullah Mohammed Al-Majid、Abdullah Saleh Alamary、Matti Haukka、Marwa M. Abu-Serie、Luis R. Domingo、Sajda Ashraf、Zaheer Ul-Haq、Mohamed S. Nafie、Mohamed Teleb

  DOI：10.1080/14756366.2023.2281260

  日期：2023.12.31